Evidence of associations between ultra-processed foods (UPF) and increased risk of cardiovascular disease is emerging, but it is unclear howmuch this is influenced by the methodology used to assess the UPF intake or by the level of consumption. We conducted a meta-analysis toevaluate 1) the association between UPF consumption and risk of diabetes, hypertension, dyslipidemia, and obesity, using prospectivecohort studies; 2) the differential associations depending on the methodology used to assess UPF intake and the level of UPF consumptionand 3) the quality of evidence using the NutriGrade scoring system. A systematic literature search was conducted in PubMed/MEDLINE, ISIWeb of Science, and Scopus through 1 April, 2023, on studies conducted in humans providing data for the highest compared with the lowestUPF consumption categories. Summary relative ratios (RRs) and 95% confidence intervals (95% CI) were estimated using a random-effectsmodel. Out of 4522 articles retrieved from the literature search, 25 reports met the criteria for inclusion in the meta-analysis, 7 for diabetes,5 for hypertension, 3 for dyslipidemia, and 13 for obesity. A consistently positive association between high UPF intake and increased risk ofdeveloping diabetes (37%), hypertension (32%), hypertriglyceridemia (47%), low HDL cholesterol concentration (43%), and obesity (32%)was observed, even if the quality of evidence was not satisfying. However, these risks varied significantly depending on the methodologyused to assess UPF consumption, with a difference of more than 50% between the methods. Based on the level of intake, we did not observesignificant differences in the results. These findings show that UPF consumption is associated with higher risk of diabetes, hypertension,dyslipidemia, and obesity, but the level of risk consistently changes depending on the methodology used to assess UPF intake. Therefore,caution should be used when interpreting and extrapolating the results.
Ultra-Processed Foods and Human Health: A Systematic Review and Meta-Analysis of Prospective Cohort Studies
Rosalba Giacco
2023
Abstract
Evidence of associations between ultra-processed foods (UPF) and increased risk of cardiovascular disease is emerging, but it is unclear howmuch this is influenced by the methodology used to assess the UPF intake or by the level of consumption. We conducted a meta-analysis toevaluate 1) the association between UPF consumption and risk of diabetes, hypertension, dyslipidemia, and obesity, using prospectivecohort studies; 2) the differential associations depending on the methodology used to assess UPF intake and the level of UPF consumptionand 3) the quality of evidence using the NutriGrade scoring system. A systematic literature search was conducted in PubMed/MEDLINE, ISIWeb of Science, and Scopus through 1 April, 2023, on studies conducted in humans providing data for the highest compared with the lowestUPF consumption categories. Summary relative ratios (RRs) and 95% confidence intervals (95% CI) were estimated using a random-effectsmodel. Out of 4522 articles retrieved from the literature search, 25 reports met the criteria for inclusion in the meta-analysis, 7 for diabetes,5 for hypertension, 3 for dyslipidemia, and 13 for obesity. A consistently positive association between high UPF intake and increased risk ofdeveloping diabetes (37%), hypertension (32%), hypertriglyceridemia (47%), low HDL cholesterol concentration (43%), and obesity (32%)was observed, even if the quality of evidence was not satisfying. However, these risks varied significantly depending on the methodologyused to assess UPF consumption, with a difference of more than 50% between the methods. Based on the level of intake, we did not observesignificant differences in the results. These findings show that UPF consumption is associated with higher risk of diabetes, hypertension,dyslipidemia, and obesity, but the level of risk consistently changes depending on the methodology used to assess UPF intake. Therefore,caution should be used when interpreting and extrapolating the results.File | Dimensione | Formato | |
---|---|---|---|
Vitale Adv Nutr 2024.pdf
accesso aperto
Tipologia:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
1.42 MB
Formato
Adobe PDF
|
1.42 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.